Prognostic value of nm23 in gastrointestinal stromal tumors

Medical Oncology

Volumn 21, Issue 1, 2004, Pages 53-57

  Kanat, Ozkan ^a   Adim, Saduman ^a   Evrensel, Turkkan ^a   Yerci, Orner ^a   Ediz, Bulent ^a   Kurt, Ender ^a   Demiray, Mutlu ^a   Gonullu, Guzin ^a   Arslan, Murat ^a   Manavoglu, Osman ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Gastrointestinal stromal tumors; nm23; Prognosis

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE A;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEOSIDE-DIPHOSPHATE KINASE; PROGNOSIS; PROTEINS; RETROSPECTIVE STUDIES; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 11144355067     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:21:1:53     Document Type: Article

References (26)

1. Pierie JP, et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001; 136:383-389.
2. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer 2002; 38(suppl 5):39-51.
3. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30:1213-1220.
4. Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 1995; 103:41-47.
5. Fletcher CD, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002; 33:459-465.
6. Steeg PS, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988; 80:200-204.
7. Terada R, et al. Clinical significance of nm23 expression and chromosome 17 numerical aberrations in primary gastric cancer. Med Oncol 2002; 19:239-248.
8. Tas F, et al. Prognostic role of nm23 gene expression in patients with ovarian cancer. Am J Clin Oncol 2002; 25:164-167.
9. Yamaguchi A, et al. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer 1994; 73:2280-2284.
10. Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB. Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst 1993; 85:727-731.
11. Chow NH, Liu HS, Chan SH. The role of nm23-H1 in the progression of transitional cell bladder cancer. Clin Cancer Res 2000; 6:3595-3599.
12. Iizuka N, et al. The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma. Cancer Lett 1999; 138:139-144.
13. Langer C, et al. Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours. Br J Surg 2003; 90:332-339.
14. Trupiano JK, Stewart RE, Misick C, Appelman HD, Goldblum JR. Gasric stromal tumors: a clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors. Am J Surg Pathol 2002; 26:705-714.
15. Abdulkader I, et al. Predictors of malignant behaviour in gastrointestinal stromal tumours: a clinicopathological study of 34 cases. Eur J Surg 2002; 168:288-296.
16. Noguchi T, et al. Biological analysis of gastrointestinal stromal tumors. Oncol Rep 2002; 9:1277-1282.
17. Yan H, et al. Prognostic assessment of gastrointestinal stromal tumor. Am J Clin Oncol 2003; 26:221-228.
18. Singer S, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 2002; 18:3898-3905.
19. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 1999; 23:82-87.
20. Sakurai S, et al. Telomerase activity in gastrointestinal stromal tumors. Cancer 1998; 83:2060-2066.
21. Miettinen M, El-Rifai W, Sobin L, Lasota J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 2002; 33:478-483.
22. Takahashi R, et al. Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology 2003; 64:266-274.
23. Heide I, et al. Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer. Br J Cancer 1994; 70:1267-1271.
24. Chen HY, Hsu CT, Lin WC, Tsai HD, Chang WC. Prognostic value of nm23 expression in stage IB1 cervical carcinoma. Jpn J Clin Oncol 2001; 31:327-332.
25. Müller W, Schneiders A, Hommel G, Gabbert H. Expression of nm23 in gastric cracinoma. Association with tumor progression and poor prognosis. Cancer 1998; 83:2481-2487.
26. Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 2003; 6:39-48.